NasdaqCM - Nasdaq Real Time Price USD

OSR Holdings, Inc. (OSRH)

1.5300
-0.1000
(-6.13%)
As of 9:36:05 AM EDT. Market Open.
Loading Chart for OSRH
  • Previous Close 1.6300
  • Open 1.5200
  • Bid 1.5700 x 100
  • Ask 1.6700 x 100
  • Day's Range 1.5200 - 1.5300
  • 52 Week Range 1.0200 - 13.4000
  • Volume 3,984
  • Avg. Volume 3,131,541
  • Market Cap (intraday) 29.494M
  • Beta (5Y Monthly) 1.62
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5400
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.

www.osr-holdings.com

19

Full Time Employees

December 31

Fiscal Year Ends

Recent News: OSRH

View More

Performance Overview: OSRH

Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

OSRH
86.73%
S&P 500 (^GSPC)
2.06%

1-Year Return

OSRH
85.77%
S&P 500 (^GSPC)
10.48%

3-Year Return

OSRH
84.85%
S&P 500 (^GSPC)
60.09%

5-Year Return

OSRH
84.85%
S&P 500 (^GSPC)
97.38%

Compare To: OSRH

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: OSRH

View More

Valuation Measures

Annual
As of 6/12/2025
  • Market Cap

    31.42M

  • Enterprise Value

    34.60M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    0.41

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    -148.95k

  • Net Income Avi to Common (ttm)

    -10.45M

  • Diluted EPS (ttm)

    -0.5400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.6M

  • Total Debt/Equity (mrq)

    3.61%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: OSRH

View More

Company Insights: OSRH

Research Reports: OSRH

View More

People Also Watch